Back to mobile site

More on XERS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.8 Score)
- Holders

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xeris Pharmaceuticals Inc. (NQ:XERS)
Delayed: 8.80 +0.60 (7.32%)
Prev. Close $8.20  
Open$8.28 
52 Wk High$ 
52 Wk Low$ 
Day High$8.81 
Day Low$8.16 
P/E N/A  
EPS$ 
Volume3,231,367 

Friends, Peers and Foes (?): BIOS, STDY, UTHR ZGNX (more...)

Sep 10, 2026 06:11 AM Oppenheimer Reiterates Outperform Rating on Xeris Pharmaceuticals (XERS)
Aug 26, 2026 07:30 AM Xeris Announces Details for XP-8121 Program Overview Webinar
Aug 21, 2026 04:23 PM Form 4 Xeris Biopharma Holdings For: Aug 01 Filed by: Shannon John Patrick Jr
Aug 21, 2026 04:16 PM Form 4 Xeris Biopharma Holdings For: Aug 01 Filed by: McCulloch Kevin
Aug 12, 2026 04:45 PM Form 4 Xeris Biopharma Holdings For: Aug 12 Filed by: Pieper Steven
Aug 12, 2026 04:38 PM Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven
Aug 6, 2026 04:11 PM Form 10-Q Xeris Biopharma Holdings For: Jun 30
Aug 6, 2026 07:13 AM Form 8-K Xeris Biopharma Holdings For: Aug 06
Aug 6, 2026 07:09 AM Xeris Pharmaceuticals Inc. (XERS) Misses Q2 EPS by 19c; Offers Guidance
Aug 6, 2026 07:00 AM Xeris Biopharma Reports Second Quarter 2026 Financial Results
View All Articles

Entities mentioned with XERS

View All Entities